Skip to main content
SpringerLink
Log in

Autoimmune diseases of muscle

  • Chapter
Immunology of Neuromuscular Disease

Part of the book series: Immunology and Medicine Series ((IMME,volume 24))

  • 53 Accesses

Abstract

This chapter focuses primarily on the immunopathogenesis, clinical features and treatment of polymyositis (PM), inclusion body myositis (IBM) and dermatomyositis (DM), the commonly encountered inflammatory myopathies. Parasitic, bacterial, spirochaetal and viral infectious myopathies are not discussed. For recent general reviews, the reader may wish to refer to references 1–5.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, editors. Myology, 2nd Edn. New York: McGraw-Hill; 1994:1335–83.

    Google Scholar 

  2. Dalakas MC. Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med. 1991;325:1487–98.

    Article  PubMed  CAS  Google Scholar 

  3. Dalakas MC. Inflammatory and toxic myopathies. Curr Opin Neurol Neurosurg. 1992;5:645–54.

    PubMed  CAS  Google Scholar 

  4. Engel AG. Inflammatory myopathies. In: Wyngaarden JB, Smith LH, Bennett JC, editors. Cecil Textbook of Medicine. Philadelphia: Saunders, 1992:2256–8.

    Google Scholar 

  5. Hohlfeld R, Engel AG. Immune responses in muscle. Semin Neurosci. 1992;4:249–55.

    Article  Google Scholar 

  6. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine. 1966;45:261–89.

    Article  PubMed  CAS  Google Scholar 

  7. Banker BQ. Dermatomyositis of childhood. Ultrastructural alterations of muscle and intramuscular blood vessels. J Neuropathol. Exp Neurol. 1975;34:46–75.

    Article  PubMed  CAS  Google Scholar 

  8. Carpenter S, Karpati G, Rothman S, Watters G. The childhood type of dermatomyositis. Neurology. 1976;26:952–62.

    Article  PubMed  CAS  Google Scholar 

  9. Jerusalem F, Rakusa M, Engel AG, MacDonald RD. Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies. J Neurol Sci. 1974;23:391–401.

    Article  PubMed  CAS  Google Scholar 

  10. Whitaker JN, Engel WK. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med. 1972;286:333–8.

    Article  PubMed  CAS  Google Scholar 

  11. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med. 1986;314:331–4.

    Article  Google Scholar 

  12. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibres invaded by T cells. Ann Neurol. 1984;16:193–208.

    Article  PubMed  CAS  Google Scholar 

  13. De Visser M, Emslie-Smith AM, Engel AG. Early ultrastructural changes in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci. 1989;94:181–92.

    Article  PubMed  Google Scholar 

  14. Emslie-Smith A, Engel AG. Microvascular changes in early and advanced dermatomyositis. A quantitative study. Ann Neurol. 1990;27:343–56.

    Article  PubMed  CAS  Google Scholar 

  15. Cervera R, Ramirez G, Fernandez-Sola J, et al. Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease. Br Med J. 1991;302:880–1.

    Article  CAS  Google Scholar 

  16. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 1984;16:209–16.

    Article  PubMed  CAS  Google Scholar 

  17. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. III. Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol. 1986;19:112–25.

    Article  PubMed  CAS  Google Scholar 

  18. Engel AG, Arahata K. Mononuclear cells in myopathies. Quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol. 1986;17:704–21.

    Article  PubMed  CAS  Google Scholar 

  19. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV. Cell-mediated cytotoxicity and muscle fibre necrosis. Ann Neurol. 1988;23:168–73.

    Article  PubMed  CAS  Google Scholar 

  20. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. V. Identification and quantification of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol. 1988;23:493–9.

    Article  PubMed  CAS  Google Scholar 

  21. Engel AG, Arahata K, Emslie-Smith AM Immune effector mechanisms in inflammatory myopathies. Res Pub Assoc Res Nerv Ment Dis. 1990;68:141–57.

    CAS  Google Scholar 

  22. Phillips JH, Lanier LL. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu7 antigen. J Immunol. 1986;136:1579–85.

    PubMed  CAS  Google Scholar 

  23. Rüthlein JH, James SP, Strober W. Role of CD2 in activation and cytotoxic function of CD8/Leu7-positive T cells. J Immunol. 1988;141:3791–7.

    PubMed  Google Scholar 

  24. Marguerie C, Lunardi C, So A. PCR-based analysis of the TCR repertoire in human autoimmune diseases. Immunol Today. 1992;13:336–8.

    Article  PubMed  CAS  Google Scholar 

  25. Mantegazza R, Andreetta F, Bernasconi P, Baggi F, Oksenberg JR, Simoncini O, Mora M, Cornelio F, Steinman L. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis: Restricted Vα/β rearrangements may indicate antigen-driven selection. J Clin Invest. 1993;91:2880–6.

    Article  PubMed  CAS  Google Scholar 

  26. Hohlfeld R. Neurological autoimmune disease and the trimolecular complex of T-lymphocytes. Ann Neurol. 1989;25:531–8.

    Article  PubMed  CAS  Google Scholar 

  27. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol. 1988;23:64–72.

    Article  PubMed  CAS  Google Scholar 

  28. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol. 1989;20:224–31.

    Article  PubMed  CAS  Google Scholar 

  29. Braciale TJ. Antigen processing for presentation by MHC class I molecules. Curr Opin Immunol. 1992;4:59–62.

    Article  PubMed  CAS  Google Scholar 

  30. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature. 1991;353:326–9.

    Article  PubMed  CAS  Google Scholar 

  31. Leff RL, Love SJ, Miller FW, et al. Viruses in idiopathic inflammatory myopathies: Absence of candidate viral genomes in muscle. Lancet. 1992;339:1192–5.

    Article  PubMed  CAS  Google Scholar 

  32. Hohlfeld R, Engel AG, Kunio I, Harper MC. Polymyositis mediated by T lymphocytes that express the γ/δ receptor. N Engl J Med. 1991;13:877–81.

    Article  Google Scholar 

  33. Pluschke G, Rüegg D, Hohlfeld R, Engel AG. Autoaggressive myocytotoxic T-lymphocytes expressing an unusual γ/δ T-cell receptor. J Exp Med. 1992;176:1785–9.

    Article  PubMed  CAS  Google Scholar 

  34. Hohlfeld R, Engel AG. Expression of 65-kd heat shock proteins in the inflammatory myopathies. Ann Neurol. 1992;32:821–3.

    Article  PubMed  CAS  Google Scholar 

  35. Blau HM, Webster C. Isolation and characterization of human muscle cells. Proc Natl Acad Sci USA. 1981;78:6523–7.

    Article  Google Scholar 

  36. Hohlfeld R, Engel AG. Induction of HLA-DR expression on human myoblasts with interferon-γ. Am J Pathol. 1990;136:503–8.

    PubMed  CAS  Google Scholar 

  37. Hohlfeld R, Engel AG. Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann Neurol. 1991;29:498–507.

    Article  PubMed  CAS  Google Scholar 

  38. Schubert W, Zimmermann K, Cramer M, Starzinsky-Powitz A. Lymphocyte antigen Leu-19 as a marker of regeneration in human skeletal muscle. Proc Natl Acad Sci USA. 1989;86:307–11.

    Article  PubMed  CAS  Google Scholar 

  39. Illa I, Leon-Monzon M, Dalakas MC. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecules recognized by monoclonal antibodies to natural killer cells. Ann Neurol. 1992;31:46–52.

    Article  PubMed  CAS  Google Scholar 

  40. Goebels N, Michaelis D, Wekerle H, Hohlfeld R. Human myoblasts as antigen presenting cells. J Immunol. 1992;149:661–7.

    PubMed  CAS  Google Scholar 

  41. Bao S, King NJC, Dosremedios CG. Elevated MHC class-I and class-II antigens in cultured human embryonic myoblasts following stimulation with γ-interferon. Immunol Cell Biol. 1990;68:235–42.

    Article  PubMed  Google Scholar 

  42. Mantegazza R, Hughes SM, Mitchell D, Travis M, Blau HM, Steinman L. Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-γ. Neurology. 1991;41:1128–32.

    Article  PubMed  CAS  Google Scholar 

  43. Roy R, Dansereau G, Tremblay JP, et al. Expression of major histocompatibility complex antigens on human myoblasts. Transplant Proc. 1991;23:799–801.

    PubMed  CAS  Google Scholar 

  44. Beauchamp JR, Abraham DJ, Bou-Gharios G, Partridge TA, Olsen I. Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture. Am J Pathol. 1992;140:387–401.

    PubMed  CAS  Google Scholar 

  45. Cifuentes-Diaz C, Delaporte C, Datreaux B, Charron D, Fardeau M. Class II MHC antigens in normal skeletal muscle. Muscle Nerve. 1992;15:295–302.

    Article  PubMed  CAS  Google Scholar 

  46. Kalovidouris AE. The role of cytokines in polymyositis: Interferon-γ induces class II and enhances class I major histocompatibility complex antigen expression on cultured human muscle cells. J Lab Clin Med. 1992;120:244–51.

    PubMed  CAS  Google Scholar 

  47. Hardiman O, Faustman D, Li X, Sklar RM, Brown RH. Expression of major histocompatibility complex antigens in cultures of clonally derived human myoblasts. Neurology. 1993;43:604–8.

    Article  PubMed  CAS  Google Scholar 

  48. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425–34.

    Article  PubMed  CAS  Google Scholar 

  49. Jäättelä M. Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab Invest. 1991;64:724–42.

    Google Scholar 

  50. Nathan C, Yoshida R. Cytokines: interferon-γ. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1988:229–51.

    Google Scholar 

  51. Michaelis D, Goebels N, Hohlfeld R. Constitutive and cytokine-induced expression of HLA and cell adhesion molecules by human myotubes. Am J Pathol. 1993;143:1142–9.

    PubMed  CAS  Google Scholar 

  52. Hohlfeld R, Engel AG. Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation. J Clin Invest. 1990;86:370–4.

    Article  PubMed  CAS  Google Scholar 

  53. Karpati G. The principles and practice of myoblast transfer. In Griggs R, Kaspar G, editors. Myoblast Transfer Therapy. New York: Plenum Press, 1990.

    Google Scholar 

  54. Karpati G, Ajdukovic D, Arnold D, et al. Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol. 1993;34:8–17.

    Article  PubMed  CAS  Google Scholar 

  55. Engel AG. Gene therapy for Duchenne dystrophy. Ann Neurol. 1993;34:3–4.

    Article  PubMed  CAS  Google Scholar 

  56. Wekerle H, Linington C, Lassmann H, Meyermann R Cellular immune reactivity within the CNS. Trends Neurosci. 1986;9:271–7.

    Article  Google Scholar 

  57. Unanue ER, Allen PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science. 1987;236:551–8.

    Article  PubMed  CAS  Google Scholar 

  58. Poher JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol. 1988;133:426–33.

    Google Scholar 

  59. Berzofsky JA, Brett SJ, Streicher HZ, Takahashi H. Antigen processing for presentation to T lymphocytes: function, mechanisms and implications for the T cell response. Immunol Rev. 1989;l06:5–3l.

    Google Scholar 

  60. Weaver CT, Unanue ER. The costimulatory function of antigen-presenting cells. Immunol Today. 1990;11:49–55.

    Article  PubMed  CAS  Google Scholar 

  61. Braciale TJ, Braciale VL. Antigen presentation: structural themes and functional variations. Immunol Today. 1991;12:124–9.

    Article  PubMed  CAS  Google Scholar 

  62. Brodsky FM, Guagliardi L. The cell biology of antigen processing and presentation. Ann Rev Immunol. 1991;9:707–44.

    Article  CAS  Google Scholar 

  63. Higuchi I, Montmayor E, Izumo S, Inose M, Osame M. Immunohistochemical characteristics of polymyositis in patients with HTLVI-associated myelopathy and HTLVI carriers. Muscle Nerve. 1993;16:472–6.

    Article  PubMed  CAS  Google Scholar 

  64. Robinson LR. AAEM case report #22: polymyositis. Muscle Nerve. 1991;14:310–15.

    Article  PubMed  CAS  Google Scholar 

  65. Illa I, Nath A, Dalakas MC. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol. 1991;29:474–81.

    Article  PubMed  CAS  Google Scholar 

  66. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondria1 myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990;322:1098–105.

    Article  PubMed  CAS  Google Scholar 

  67. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Resp Dis. 1990;141:727–33.

    Article  PubMed  CAS  Google Scholar 

  68. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis - a population-based study. N Engl J Med. 1992;326: 363–7.

    Article  PubMed  CAS  Google Scholar 

  69. Bernard P, Bonnetblanc JM. Dermatomyositis and malignancy. J Invest Dermatol. 1993;100:128S–132S.

    Article  PubMed  CAS  Google Scholar 

  70. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Brain. 1969;112:727–42.

    Article  Google Scholar 

  71. Massa R, Weller B, Karpati G, Shoubridge E, Carpenter S. Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol. 1991;48:519–22.

    Article  PubMed  CAS  Google Scholar 

  72. Askanas V, Serdaroglu P, Engel WK, Alvarez RB. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci Lett. 199l;130:73–6.

    Article  PubMed  CAS  Google Scholar 

  73. Askanas V, Engel WK, Alvarez RB. Light and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion body myositis. Am J Pathol. 1992;141:31–6.

    PubMed  CAS  Google Scholar 

  74. Jann S, Beretta S, Moggio M, Adobbati L, Pellegrini G. High-dose intravenous human immunoglobulin in polymyositis resistant to treatment. J Neurol Neurosurg Psychiatry. 1992;55:60–2.

    Article  CAS  Google Scholar 

  75. Miller FW, Leitman SF, Cronin ME, et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med. 1992;326:1380–4.

    Article  PubMed  CAS  Google Scholar 

  76. Dau PC. Plasma exchange in polymyositis and dermatomyositis. N Engl J Med. 1992;327:1030.

    Article  PubMed  CAS  Google Scholar 

  77. Al-Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol. 1989;16:1592–6.

    PubMed  CAS  Google Scholar 

  78. Soueidan SA, Dalakas MC. Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin. Neurology. 1993;43:876–9

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Hohlfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. G. Engel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Munich, Germany

    R. Hohlfeld

  2. Department of Neuroimmunology, Max-Planck Institute, Martinsried, Germany

    R. Hohlfeld

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hohlfeld, R., Engel, A.G. (1994). Autoimmune diseases of muscle. In: Hohlfeld, R. (eds) Immunology of Neuromuscular Disease. Immunology and Medicine Series, vol 24. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1422-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1422-6_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4622-0

  • Online ISBN: 978-94-011-1422-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation